Breaking News Instant updates and real-time market news.

MAT

Mattel

$14.99

0.155 (1.04%)

, HAS

Hasbro

$90.07

-1.39 (-1.52%)

14:35
03/13/18
03/13
14:35
03/13/18
14:35

Toys R Us said to have missed payments to vendors, Bloomberg reports

Toys R Us, which filed for bankruptcy protection in September, has stopped making payments to some suppliers in recent days without any explanation, according to Bloomberg, citing people with knowledge of the matter. The company has also stopped negotiating settlements with vendors it owes money to, the report added. Jefferies analyst Stephanie Wissink has previously noted that the top three toymakers most exposed to Toys R Us are Mattel (MAT), Hasbro (HAS) and JAKKS Pacific (JAKK).

MAT

Mattel

$14.99

0.155 (1.04%)

HAS

Hasbro

$90.07

-1.39 (-1.52%)

JAKK

JAKKS Pacific

$2.25

-0.1 (-4.26%)

MAT Mattel
$14.99

0.155 (1.04%)

03/09/18
03/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mattel (MAT) downgraded to Underweight from Equal Weight at Barclays, with analyst Felicia Hendrix saying Mattel faces downside risk from the potential Toys R Us liquidation. 2. Himax (HIMX) downgraded to Market Perform from Outperform at Northland and to Neutral from Buy at Nomura Instinet. 3. Ecopetrol (EC) downgraded to Underperform from Hold at Santander. 4. Acacia Communications (ACIA) downgraded to Underweight from Equal Weight at Morgan Stanley, with analyst Meta Marshall saying he thinks Wall Street estimates remain too high for 2019 as he does not see a rebound in Acacia's biggest markets -- namely China and datacomm systems -- being as lucrative as consensus expectations given competition and pricing pressures. 5. Match Group (MTCH) downgraded to Market Perform from Outperform at Wells Fargo, with analyst Peter Stabler saying he believes further share appreciation will need to rely "more squarely on positive revisions rather than multiple expansion." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/09/18
LEHM
03/09/18
DOWNGRADE
Target $13
LEHM
Underweight
Barclays downgrades Mattel to Underweight on possible Toys R Us liquidation
Barclays analyst Felicia Hendrix downgraded Mattel (MAT) to Underweight from Equal Weight and cut her price target for the shares to $13 from $16. The analyst maintains an Overweight rating on Hasbro (HAS) while trimming her target for the stock to $100 from $110. Mattel faces downside risk from the potential Toys R Us liquidation, Hendrix tells investors in a research note. The company generates 8% of its sales from Toys R Us and its shares are up 4% since reporting earnings on February 1, the analyst notes. She believes sell-side estimates for both Mattel and Hasbro likely only include the closure of 182 Toys R Us U.S. stores. The analyst finds Hasbro's risk/reward more favorable at current share levels.
03/09/18
LEHM
03/09/18
DOWNGRADE
LEHM
Underweight
Mattel downgraded to Underweight from Equal Weight at Barclays
02/26/18
02/26/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Albermarle (ALB) downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Vincent Andrews, who cited concerns on both the lithium supply and demand side. On the lithium demand side, bulls' electric vehicle penetration rate forecasts seem "aggressive, said Andrews. He also now has material concerns on the supply side following the recent Chilean government agreement with SQM (SQM), added Andrews. SQM was also downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Javier Martinez de Olcoz Cerdan. 2. Halliburton (HAL) downgraded to Neutral from Buy at BofA/Merrill by analyst Timna Tanners, who said the U.S. shale story is maturing and there are limited catalysts for shares. Tanners expects a more muted response to high oil prices given newbuiilds coming into the market in 2018. 3. Aqua America (WTR) downgraded to Market Perform from Outperform at Wells Fargo by analyst Jonathan Reeder, who cited valuation and said he prefers shares of American Water (AWK) at current levels. 4. Mattel (MAT) downgraded to Underperform from Hold at Jefferies by analyst Stephanie Wissink. The shares currently reflect an "aggressive" sales and profit recovery to 15% margins in 2020, Wissink said, however, believes industry conditions are challenging recovery assumptions. 5. Empire State Realty (ESRT) downgraded to Hold from Buy at Stifel by analyst John Guinee, who said he expects 2018 to be a "difficult year for value creation metrics" and notes his FFO estimates continue to decline. Guinee added that the Manhattan investment market is highly competitive and that he's not convinced the company will deploy the cash balance into new investments any time soon. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HAS Hasbro
$90.07

-1.39 (-1.52%)

02/08/18
WELS
02/08/18
NO CHANGE
Target $100
WELS
Market Perform
Hasbro price target raised to $100 from $95 at Wells Fargo
Wells Fargo analyst Tim Conder raised his price target for Hasbro to $100 from $95 as Q4 revenue/margins were not as bad as feared precipitating short covering, but core underlying earnings quality deteriorated. The analyst reiterates a Market Perform rating on the shares.
03/08/18
BMOC
03/08/18
NO CHANGE
Target $96
BMOC
Market Perform
Hasbro price target lowered to $96 from $100 at BMO Capital
BMO Capital analyst Gerrick Johnson lowered his price target on Hasbro to $96 and kept his Market Perform rating in the wake of last month's annual New York Toy Fair. Johnson writes that while the company has executed well in its "solid strategy", his meetings with the management of the company as well as those of its peers suggest that the U.S. toy market is expected to be flat with some added uncertainty related to the bankruptcy of Toys R Us, evolving retail landscape, and the underperformance of movie toys. The analyst adds that while Hasbro is gaining share with its "new approach to product development", its valuation is at a premium of 17-times forward multiple vs. 15-times historical average.
02/08/18
BMOC
02/08/18
NO CHANGE
Target $100
BMOC
Market Perform
Hasbro price target raised to $100 from $83 at BMO Capital
BMO Capital analyst Gerrick Johnson raised his price target on Hasbro to $100 after the company's Q4 earnings beat, but notes that operating performance was "well below expectations", with gross margins missing estimates and Star Wars segment trending softly. Johnson keeps his Market Perform rating on Hasbro, adding that the stock typically rallies into the Toy Fair scheduled for February 16th and sees the focus turning to the release of Frozen 2.
JAKK JAKKS Pacific
$2.25

-0.1 (-4.26%)

09/21/17
DADA
09/21/17
DOWNGRADE
DADA
Underperform
JAKKS Pacific downgraded after guidance reduction at DA Davidson
As noted earlier, DA Davidson downgraded JAKKS to Underperform from Neutral. Analyst Linda Bolton Weiser downgraded the stock after JAKKS cut its 2017 guidance and said it expects its EBITDA to drop year-over-year.Weiser says that JAKKS' stock probably rose in the wake of the guidance reductions because the company revealed that uninsured payments from Toys R' Us accounted for only 3% of its accounts receivable. However, the analyst noted that she now expects the company's 2017 EBITDA to fall 27% year-over-year, and she thinks that 2H17 consensus estimates could be too high, given Toys R Us' situation. The analyst is not confident about the company's 2018 EBITDA outlook and notes that it has been issuing stock to reduce its debt. Target $2.25.
10/30/17
DADA
10/30/17
UPGRADE
Target $3
DADA
Neutral
JAKKS Pacific upgraded to Neutral at DA Davidson on valuation
As noted earlier, DA Davidson analyst Linda Bolton Weiser upgraded JAKKS Pacific to Neutral from Underperform and raised her price target to $3.00 from $2.25. The analyst says the year-to-date free cash flow exceeded her forecasts, noting improvement in the company's working capital. Given the increased visibility on JAKKS' ability to replay the 2018 converts and the 16% slide in stock price since October 23rd, the analyst is upgrading her rating.
10/30/17
DADA
10/30/17
UPGRADE
DADA
Neutral
JAKKS Pacific upgraded to Neutral from Underperform at DA Davidson
09/21/17
09/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Hanesbrands (HBI) downgraded to Neutral from Buy at Nomura Instinet with analyst Simeon Siegel citng the stock's rise of over 14% year-to-date. 2. Biogen (BIIB) downgraded to Market Perform from Outperform at Raymond James with analyst Laura Chico citing the latest MS survey feedback that continues to show headwinds to the franchise. 3. Terex (TEX) downgraded to Hold from Buy at Deutsche Bank with analyst Nicole DeBlase citing valuation with the shares up 39% year-to-date. 4. JAKKS Pacific (JAKK) downgraded to Underperform from Neutral at DA Davidson with analyst Linda Bolton Weiser saying it expects its EBITDA to drop year-over-year. 5. USG (USG) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TLND

Talend

$49.40

-1.81 (-3.53%)

09:36
03/25/19
03/25
09:36
03/25/19
09:36
Recommendations
Talend analyst commentary  »

Talend price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHI

Robert Half

$63.78

-2.58 (-3.89%)

09:36
03/25/19
03/25
09:36
03/25/19
09:36
Hot Stocks
Breaking Hot Stocks news story on Robert Half »

Robert Half mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$109.51

-2.68 (-2.39%)

09:35
03/25/19
03/25
09:35
03/25/19
09:35
Downgrade
Texas Instruments rating change  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TXN

Texas Instruments

$109.51

-2.68 (-2.39%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Downgrade
Texas Instruments rating change  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LNTH

Lantheus

$23.61

-1.575 (-6.25%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Hot Stocks
Lantheus promotes John Bolla to COO »

Lantheus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

MEOH

Methanex

$57.73

-2.64 (-4.37%)

09:33
03/25/19
03/25
09:33
03/25/19
09:33
Hot Stocks
M&G Investments announces four director nominees for Methanex board »

M&G Investments, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$41.28

0.75 (1.85%)

09:32
03/25/19
03/25
09:32
03/25/19
09:32
Recommendations
D.R. Horton analyst commentary  »

D.R. Horton benefiting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LNTH

Lantheus

$23.61

-1.575 (-6.25%)

09:31
03/25/19
03/25
09:31
03/25/19
09:31
Hot Stocks
Lantheus announces upcoming retirement of Chief Medical Officer in September »

Lantheus Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

NEON

Neonode

$2.80

(0.00%)

09:28
03/25/19
03/25
09:28
03/25/19
09:28
Hot Stocks
Neonode says Convergence Promotions to act as sales and marketing partner »

Neonode announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLXP

PLx Pharma

$5.54

-0.525 (-8.66%)

09:27
03/25/19
03/25
09:27
03/25/19
09:27
Syndicate
Breaking Syndicate news story on PLx Pharma »

PLx Pharma files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEX

Wex

$184.59

-6.555 (-3.43%)

09:26
03/25/19
03/25
09:26
03/25/19
09:26
Hot Stocks
Wex to acquire fuel card business of EG Group »

WEX announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IART

Integra LifeSciences

$55.29

-2.07 (-3.61%)

09:25
03/25/19
03/25
09:25
03/25/19
09:25
Conference/Events
Integra LifeSciences participates in a conference call with JPMorgan »

Medical Supplies &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

PTI

Proteostasis

$4.17

-0.14 (-3.25%)

, VRTX

Vertex

$181.49

-1.07 (-0.59%)

09:25
03/25/19
03/25
09:25
03/25/19
09:25
Recommendations
Proteostasis, Vertex analyst commentary  »

Piper sees 'clear…

PTI

Proteostasis

$4.17

-0.14 (-3.25%)

VRTX

Vertex

$181.49

-1.07 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 10

    Apr

09:25
03/25/19
03/25
09:25
03/25/19
09:25
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

09:25
03/25/19
03/25
09:25
03/25/19
09:25
General news
A Spring Rebound for Producer Sentiment »

A Spring Rebound for…

09:25
03/25/19
03/25
09:25
03/25/19
09:25
Conference/Events
The U.S. Commodity Futures Trading Commission to hold a meeting »

Open Commission Meeting…

ORGS

Orgenesis

$5.01

-0.19 (-3.65%)

09:24
03/25/19
03/25
09:24
03/25/19
09:24
Hot Stocks
Orgenesis to establish new facility for cell, gene therapy manufacturing »

Orgenesis announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$3.06

0.28 (10.07%)

09:24
03/25/19
03/25
09:24
03/25/19
09:24
Recommendations
Avon Products analyst commentary at DA Davidson »

Avon Products buyout…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSL

MidSouth Bancorp

$10.22

-0.49 (-4.58%)

09:23
03/25/19
03/25
09:23
03/25/19
09:23
Upgrade
MidSouth Bancorp rating change  »

Sandler O'Neill says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:21
03/25/19
03/25
09:21
03/25/19
09:21
Conference/Events
JPMorgan retail analyst to hold an analyst/industry conference call »

Broadlines &…

PLAN

Anaplan

$38.98

-1.47 (-3.63%)

09:21
03/25/19
03/25
09:21
03/25/19
09:21
Initiation
Anaplan initiated  »

Anaplan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDOR

Condor Hospitality Trust

$8.70

(0.00%)

09:19
03/25/19
03/25
09:19
03/25/19
09:19
Hot Stocks
Condor Hospitality Trust announces sale of non-core legacy hotel »

Condor Hospitality Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
03/25/19
03/25
09:18
03/25/19
09:18
Options
Overnight activity included 349 trades in SPX and 231 trades in VIX »

349 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTDR

Frontdoor

$32.78

0.38 (1.17%)

09:16
03/25/19
03/25
09:16
03/25/19
09:16
Initiation
Frontdoor initiated  »

Frontdoor initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$79.94

-1.29 (-1.59%)

09:15
03/25/19
03/25
09:15
03/25/19
09:15
Downgrade
AbbVie rating change  »

AbbVie downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.